世界の放射線毒性（放射線障害、急性放射線症候群）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z11704
• 出版社/出版日：GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、放射線毒性（放射線障害、急性放射線症候群）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。放射線毒性（放射線障害、急性放射線症候群）の種類別市場規模（輸血、抗生物質、その他）、用途別市場規模（病院、診療所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・放射線毒性（放射線障害、急性放射線症候群）の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Aeolus Pharmaceuticals, Inc.、Atox Bio Ltd、BCN Biosciences LLC、Cellphire Inc、Daiichi Sankyo Co Ltd、FirstString Research Inc、RxBio Inc、Shuttle Pharmaceuticals LLC
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：輸血、抗生物質、その他
・用途別分析2016年-2026年：病院、診療所
・放射線毒性（放射線障害、急性放射線症候群）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・放射線毒性（放射線障害、急性放射線症候群）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・放射線毒性（放射線障害、急性放射線症候群）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・放射線毒性（放射線障害、急性放射線症候群）の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・放射線毒性（放射線障害、急性放射線症候群）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Blood Transfusion
Antibiotic
Others

Market segment by Application, can be divided into
Hospital
Clinic

Market segment by players, this report covers
Aeolus Pharmaceuticals, Inc.
Atox Bio Ltd
BCN Biosciences LLC
Cellphire Inc
Daiichi Sankyo Co Ltd
FirstString Research Inc
RxBio Inc
Shuttle Pharmaceuticals LLC

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
1.2 Classification of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) by Type
1.2.1 Overview: Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Type in 2020
1.2.3 Blood Transfusion
1.2.4 Antibiotic
1.2.5 Others
1.3 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market by Application
1.3.1 Overview: Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size & Forecast
1.5 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast by Region
1.5.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region, (2016-2021)
1.5.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Prospect (2016-2026)
1.5.4 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Prospect (2016-2026)
1.5.6 South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers
1.6.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
1.6.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Trends Analysis
2 Company Profiles
2.1 Aeolus Pharmaceuticals, Inc.
2.1.1 Aeolus Pharmaceuticals, Inc. Details
2.1.2 Aeolus Pharmaceuticals, Inc. Major Business
2.1.3 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
2.1.4 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Aeolus Pharmaceuticals, Inc. Recent Developments and Future Plans
2.2 Atox Bio Ltd
2.2.1 Atox Bio Ltd Details
2.2.2 Atox Bio Ltd Major Business
2.2.3 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
2.2.4 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Atox Bio Ltd Recent Developments and Future Plans
2.3 BCN Biosciences LLC
2.3.1 BCN Biosciences LLC Details
2.3.2 BCN Biosciences LLC Major Business
2.3.3 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
2.3.4 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 BCN Biosciences LLC Recent Developments and Future Plans
2.4 Cellphire Inc
2.4.1 Cellphire Inc Details
2.4.2 Cellphire Inc Major Business
2.4.3 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
2.4.4 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Cellphire Inc Recent Developments and Future Plans
2.5 Daiichi Sankyo Co Ltd
2.5.1 Daiichi Sankyo Co Ltd Details
2.5.2 Daiichi Sankyo Co Ltd Major Business
2.5.3 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
2.5.4 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Daiichi Sankyo Co Ltd Recent Developments and Future Plans
2.6 FirstString Research Inc
2.6.1 FirstString Research Inc Details
2.6.2 FirstString Research Inc Major Business
2.6.3 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
2.6.4 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 FirstString Research Inc Recent Developments and Future Plans
2.7 RxBio Inc
2.7.1 RxBio Inc Details
2.7.2 RxBio Inc Major Business
2.7.3 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
2.7.4 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 RxBio Inc Recent Developments and Future Plans
2.8 Shuttle Pharmaceuticals LLC
2.8.1 Shuttle Pharmaceuticals LLC Details
2.8.2 Shuttle Pharmaceuticals LLC Major Business
2.8.3 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
2.8.4 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Shuttle Pharmaceuticals LLC Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players Market Share
3.2.2 Top 10 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players Market Share
3.2.3 Market Competition Trend
3.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Market Share by Type (2016-2021)
4.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Application (2016-2021)
5.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2016-2026)
6.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2016-2026)
6.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
6.3.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2016-2026)
6.3.2 United States Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
6.3.3 Canada Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
6.3.4 Mexico Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2016-2026)
7.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2016-2026)
7.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
7.3.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2016-2026)
7.3.2 Germany Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
7.3.3 France Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
7.3.5 Russia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
7.3.6 Italy Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2016-2026)
8.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2016-2026)
8.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region
8.3.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Region (2016-2026)
8.3.2 China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
8.3.3 Japan Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
8.3.4 South Korea Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
8.3.5 India Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
8.3.7 Australia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2016-2026)
9.2 South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2016-2026)
9.3 South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
9.3.1 South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2016-2026)
9.3.2 Brazil Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
9.3.3 Argentina Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2016-2026)
10.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2016-2026)
10.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
10.3.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2016-2026)
10.3.2 Turkey Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
10.3.4 UAE Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Region (2021-2026)
Table 6. Aeolus Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Aeolus Pharmaceuticals, Inc. Major Business
Table 8. Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
Table 9. Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Atox Bio Ltd Corporate Information, Head Office, and Major Competitors
Table 11. Atox Bio Ltd Major Business
Table 12. Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
Table 13. Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. BCN Biosciences LLC Corporate Information, Head Office, and Major Competitors
Table 15. BCN Biosciences LLC Major Business
Table 16. BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
Table 17. BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Cellphire Inc Corporate Information, Head Office, and Major Competitors
Table 19. Cellphire Inc Major Business
Table 20. Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
Table 21. Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Daiichi Sankyo Co Ltd Corporate Information, Head Office, and Major Competitors
Table 23. Daiichi Sankyo Co Ltd Major Business
Table 24. Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
Table 25. Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. FirstString Research Inc Corporate Information, Head Office, and Major Competitors
Table 27. FirstString Research Inc Major Business
Table 28. FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
Table 29. FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. RxBio Inc Corporate Information, Head Office, and Major Competitors
Table 31. RxBio Inc Major Business
Table 32. RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
Table 33. RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Shuttle Pharmaceuticals LLC Corporate Information, Head Office, and Major Competitors
Table 35. Shuttle Pharmaceuticals LLC Major Business
Table 36. Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product and Solutions
Table 37. Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million) by Players (2019-2021)
Table 39. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Share by Players (2019-2021)
Table 40. Breakdown of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players Head Office, Products and Services Provided
Table 42. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Mergers & Acquisitions in the Past Five Years
Table 43. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) New Entrants and Expansion Plans
Table 44. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million) by Type (2016-2021)
Table 45. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Share by Type (2016-2021)
Table 46. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Forecast by Type (2021-2026)
Table 47. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2016-2021)
Table 48. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Forecast by Application (2021-2026)
Table 49. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Picture
Figure 2. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Type in 2020
Figure 3. Blood Transfusion
Figure 4. Antibiotic
Figure 5. Others
Figure 6. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Region (2016-2026)
Figure 12. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Region in 2020
Figure 13. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers
Figure 18. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
Figure 19. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Trends
Figure 20. Aeolus Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 21. Atox Bio Ltd Recent Developments and Future Plans
Figure 22. BCN Biosciences LLC Recent Developments and Future Plans
Figure 23. Cellphire Inc Recent Developments and Future Plans
Figure 24. Daiichi Sankyo Co Ltd Recent Developments and Future Plans
Figure 25. FirstString Research Inc Recent Developments and Future Plans
Figure 26. RxBio Inc Recent Developments and Future Plans
Figure 27. Shuttle Pharmaceuticals LLC Recent Developments and Future Plans
Figure 29. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Share by Players in 2020
Figure 30. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share in 2020
Figure 32. Global Top 10 Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Share by Type in 2020
Figure 35. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share Forecast by Type (2021-2026)
Figure 36. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Share by Application in 2020
Figure 37. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share Forecast by Application (2021-2026)
Figure 38. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Sales Market Share by Type (2016-2026)
Figure 39. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Sales Market Share by Application (2016-2026)
Figure 40. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Country (2016-2026)
Figure 41. United States Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Sales Market Share by Type (2016-2026)
Figure 45. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Sales Market Share by Application (2016-2026)
Figure 46. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Country (2016-2026)
Figure 47. Germany Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Region (2016-2026)
Figure 55. China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Sales Market Share by Type (2016-2026)
Figure 62. South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Sales Market Share by Application (2016-2026)
Figure 63. South America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source

Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Status and Forecast 2021-2027
QYR2104Z4903 2021年4月 96Pages
QYResearch社発行の本調査資料では、放射線毒性（放射線障害、急性放射線症候群）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（輸血、抗生物質、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の急性冠症候群（ACS）市場規模・現状・予測（2021年-2027年）

Global Acute Coronary Syndrome (ACS) Market Size, Status and Forecast 2021-2027
QYR2104Z0055 2021年4月 94Pages
QYResearch社発行の本調査資料では、急性冠症候群（ACS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（病院、外来手術センター、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の重症急性呼吸器症候群（SARS）治療薬市場規模・現状・予測（2021年-2027年）

Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5204 2021年4月 93Pages
QYResearch社発行の本調査資料では、重症急性呼吸器症候群（SARS）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CEL-1000、D-3252、FDX-000、INO-4500、LCA-60、その他）、用途別市場規模（病院、診...

世界のアフリカ馬疫治療市場 2021：企業別、地域別、種類・用途別

Global African Horse Sickness Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z00446 2021年4月 104Pages
当調査資料では、アフリカ馬疫治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アフリカ馬疫治療の種類別市場規模（臨床型、診断）、用途別市場規模（臨床検査、血清学的検査）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米...

世界の乗り物酔い用パッチ市場 2021：企業別、地域別、種類・用途別

Global Motion Sickness Patch Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z09593 2021年4月 101Pages
当調査資料では、乗り物酔い用パッチのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。乗り物酔い用パッチの種類別市場規模（耳後ろパッチ、へそパッチ、その他）、用途別市場規模（家庭用、業務用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、...

世界の乗り物酔い用製品市場規模・現状・予測（2021年-2027年）

Global Motion Sickness Products Market Size, Status and Forecast 2021-2027
QYR2104Z3919 2021年4月 93Pages
QYResearch社発行の本調査資料では、乗り物酔い用製品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医療、機器）、用途別市場規模（自動車、船舶、飛行機、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の睡眠病検査市場規模・現状・予測（2021年-2027年）

Global Sleeping Sickness Testing Market Size, Status and Forecast 2021-2027
QYR2104Z5289 2021年4月 90Pages
QYResearch社発行の本調査資料では、睡眠病検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アクティブスクリーニング検査、ステージ診断検査）、用途別市場規模（病院、診療所、診断センター及び研究所、学術機関）、主要地域別市場規模（北米、...

世界のアフリカ馬疫治療市場規模・現状・予測（2021年-2027年）

Global African Horse Sickness Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0155 2021年4月 90Pages
QYResearch社発行の本調査資料では、アフリカ馬疫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（臨床形態、診断）、用途別市場規模（臨床検査、血清学的検査）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イ...

世界の火災・煙・毒性抑制剤（FST）複合樹脂市場 2021：企業別、地域別、種類・用途別

Global Fire, Smoke, and Toxicity Retardant (FST) Composite Resin Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z05671 2021年4月 103Pages
当調査資料では、火災・煙・毒性抑制剤（FST）複合樹脂のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。火災・煙・毒性抑制剤（FST）複合樹脂の種類別市場規模（低煙ハロゲンフリー素材、ポリ塩化ビニル、エチレンプロピレンゴム、その他）、用途別市場規模（建築...

世界のT細胞急性リンパ芽球性白血病治療市場 2021：企業別、地域別、種類・用途別

Global T-cell Acute Lymphoblastic Leukemia Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z13634 2021年4月 100Pages
当調査資料では、T細胞急性リンパ芽球性白血病治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。T細胞急性リンパ芽球性白血病治療の種類別市場規模（化学療法、放射線療法、骨髄移植、標的療法、免疫療法）、用途別市場規模（病院、診療所、その他）、地域別市場規...

世界の放射線毒性（放射線障害、急性放射線症候群）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market The global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 20…
世界の放射線治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Radiation Therapy Market The global Radiation Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a…
世界の医療用放射線遮蔽市場規模・現状・予測（2021年-2027年） The growth of this market is mainly driven by factors such as growing incidences of cancer, increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment of Cancer, increasing number of diagnostic imaging centers and installation bases of radiology equipment. Geographically,…
世界の放射線処理市場 2021：企業別、地域別、種類・用途別 The Radiation Processing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
世界の放射線皮膚炎治療市場規模・現状・予測（2021年-2027年） The pathophysiology of a radiation skin reaction is a combination of radiation injury and the subsequent inflammatory response and can occur at both the entrance and exit site of the irradiation. The major factor driving the radiation dermatitis treatment market is the increasing prevalence of cance…